Oct 13, 2017
Steve Hill — Healthy aging what does it even mean?
Posted by Steve Hill in category: life extension
Healthy aging what does it even mean? bigsmile
#CrowdfundTheCure for #aging at www.lifespan.io
Healthy aging what does it even mean? bigsmile
#CrowdfundTheCure for #aging at www.lifespan.io
Our cells face stress from toxins such as smoke, pollution, and UV light. Without stress resistance, it can cause damage & inflammation.
ellagic acid, lignans, flavonoids, glucosinolates, curcumin, resveratrol and other bioactive compounds – are natural substances found in plants. Research has shown that these natural compounds help to prevent stroke, cancer, type 2 diabetes, heart disease, and premature death.
What Are Phytonutrients?
Whole plants contain thousands of natural compounds, called phytonutrients and phytochemicals. Deriving their name from phyto, the Greek word for plant, the terms are used interchangeably used to describe the health-promoting compounds found in all whole plants. While plants produce these chemicals to protect themselves from insects, germs, and fungi. Along with fiber, phytonutrients in our diet are the reason that fruits and vegetables help to prevent chronic diseases like cancer, stroke, heart disease, and premature death.
Intel’s quantum computing efforts have yielded a new 17-qubit chip, which the company has just delivered to its partner in that field, QuTech in the Netherlands. It’s not a major advance in the actual computing power or applications — those are still in very early days — but it’s a step toward production systems that can be ordered and delivered to spec rather than experimental ones that live in a physics lab somewhere.
Intel’s celebration of this particular chip is a bit arbitrary; 17 isn’t some magic number in the quantum world, nor does this chip do any special tricks other quantum computer systems can’t. Intel is just happy that its history and undeniable expertise in designing and fabricating chips and architectures is paying off in a new phase of computing.
I chatted with Intel’s director of quantum hardware, Jim Clarke, about the new system.
WASHINGTON — General Atomics is better known for building Predator combat drones and mining uranium than building spacecraft, but that could change as the company develops an interest in building defense-focused cubesats.
Also in the realm of possibility: using expertise from building railguns to design a large, electromagnetic cannon as a means to orbit small satellites.
Nick Bucci, vice president of missile defense and space systems for General Atomic’s Electromagnetic Systems Group, said the company has built 11 cubesats for the U.S. Army over the past seven years, and is gradually becoming more and more invested in space.
Continue reading “General Atomics ramping cubesat production, muses railgun smallsat launcher” »
https://www.youtube.com/watch?v=tUOu9RpzwJI
Has mobilized a team of the most experienced, connected and passionately curious minds from the US intelligence community, including the CIA and Department of Defense, that have been operating under the shadows of top-secrecy for decades.
Tom Delonge and the team members all share a common thread of frustration and determination to disrupt the status quo and want to use their expertise and credibility to bring transformative science and engineering out of the shadows and collaborate with global citizens to apply that knowledge in a way that benefits humanity.
While some automakers look to electrify conventional trucks, General Motors has taken a much more radical approach in its development of next-generation commercial vehicles.
Meet the Silent Utility Rover Universal Superstructure, or SURUS for short.
Unveiled on Friday ahead of the fall meeting of the Association of the United States Army, where it will be presented on Monday, the SURUS is essentially a modular platform designed for heavy-duty trucks that will enable near-silent running, zero harmful emissions, and autonomous operation.
Continue reading “SURUS: GM’s modular platform for silent, self-driving trucks” »
Hyperloop One has received a significant investment in Hyperloop One — the official figure hasn’t been revealed, but it’s enough that the Hyperloop tech startup, which aims to create networks of high-speed transportation tunnels to various locales across the globe, has changed its name. Virgin Hyperloop One is the entity’s official moniker going forward, which is quite a mouthful.
Virgin Hyperloop One’s rebrand will mean it gains from association with Virgin Group founder Richard Branson, whose high-tech transportation exploits include Virgin Galactic and other space-based ventures. The goal of the company under the rebrand remains the same, and it’ll continue to explore the best places and partners for deploying its high-speed transportation tech, which will zoom pods at high speed down extremely low-pressure tubes to reduce trip times over land from hours to minutes.
The money isn’t the only connection between Hyperloop One and Virgin; the Hyperloop company’s president of engineering, Josh Giegel, is a former Virgin employee. Branson noted in a blog post that he also visited Hyperloop One earlier this summer to view its technology first-hand, at the Hyperloop One DevLoop test track site in Nevada, outside Las Vegas.
Continue reading “Investors Haven’t Seen an Opportunity Like This in Decades” »
(Medical Xpress)—A team of researchers with Kyoto University and Kagawa University, both in Japan, has cured renal anemia in mice by injecting them with treated human stem cells. In their paper published in Science Translational Medicine, the group describes their approach and how well it worked.
Chronic kidney disease is a serious ailment resulting in a host of symptoms due to the body’s reduced ability to process waste and fluids—many patients eventually experience renal failure, which requires them to undergo routine dialysis or a kidney transplant. Less well known is that people with chronic kidney disease also suffer from renal anemia because the kidneys manufacture the hormone erythropoietin (EPO), which causes the body to produce red blood cells without which the blood cannot carry enough oxygen to the brain and other body parts. The current treatment for renal anemia is injections of EPO every few days, which, for many people, is impractical because of the cost and side effects. In this new effort, the researchers have found a possible new treatment—injecting treated stem cells directly into the kidneys.
In their experiments, the researchers collected stem cells from human cord blood (from the umbilical cord) and then treated them with growth factors that changed them to pluripotent stem cells that grew into mature cells capable of producing EPO. The team then injected the treated cells into the kidneys of mice suffering from renal anemia and monitored them for the rest of their lives.
Continue reading “Human stem cells used to cure renal anemia in mice” »